Skip to content
雅宝 · 官方动态·PicksAI score62.0

雅宝公布2026年第二季度业绩并上调特种化学品全年展望

Albemarle Reports Second Quarter 2026 Results

Public on this site

AI summary

雅宝公布2026年第二季度净销售额17亿美元,同比增长31%,净利润4.8亿美元,调整后EBITDA为8.58亿美元、同比增长155%,主要来自储能业务定价上涨和特种化学品量价齐升。

Why it matters

雅宝二季度业绩与全年展望披露了锂价情景下的收入与利润区间,可用于观察锂价对生产商财务的传导。

Text · AI translation

The translation is incomplete; switch to the original for the full text.

,/PRNewswire/ -- 雅宝(Albemarle Corporation)(NYSE: ALB)是为出行、能源、连接和健康提供关键要素的全球领导者,今日公布了截至2026年6月30日的第二季度业绩。

2026年第二季度及近期亮点
(除另有说明外,所有百分比变动均为同比比较,且未剔除Ketjen炼油催化剂解决方案业务上一期间的业绩;公司已于2026年3月2日出售该业务51%的股权)

  • 净销售额17亿美元,增长31%,原因是储能业务定价提高(+73%)以及特种产品业务定价和销量均上升(价格+11%,销量+8%)。
  • 归属于普通股股东的净利润为4.8亿美元,即每股摊薄收益3.52美元。  
  • 调整后EBITDA(a) 为8.58亿美元;增长155%,主要由于储能业务定价上升、特种业务定价和销量增长以及持续的成本和生产率改善。调整后EBITDA在储能(+229%)和特种(+61%)两项业务中均实现增长。
  • 经营活动产生的现金为7.10亿美元,自由现金流为6.38亿美元(a)。经营现金流转化率为83%(a),主要受Talison合资企业股息增加的时间安排以及非经常性营运资金收益的推动。
  • 年初至今已实现1亿美元的年化成本与生产率改善,正朝着我们全年1亿至1.5亿美元目标的高端迈进。经营活动产生的现金为7.1亿美元,自由现金流为6.38亿美元(a)。经营现金流转化率为83%(a),主要得益于Talison合资企业股息增加的时间安排以及非经常性营运资金收益。
  • 改善2026年全年展望的考量因素包括:
    • 将全年Specialties净销售额展望上调至14亿至16亿美元,调整后EBITDA展望上调至2.75亿至3.25亿美元,原因是年初至今的定价和销量表现强于预期。
    • 预计6月9日Talison CGP3火灾对储能销量影响极小,部分原因是Wodgina矿的产量好于计划。
    • 由于持续的资本效率改善,将全年资本支出预测下调至约5亿美元。

(a) 详见非GAAP调节表。

“雅宝(Albemarle)本季度再次取得强劲业绩,反映出定价改善、特种产品业务持续强劲、严格的成本与生产率执行以及强劲的现金生成能力,”董事长兼首席执行官Kent Masters表示。“我们继续看到核心市场(包括储能、电动汽车和半导体)的需求基本面保持韧性。我们正在推进价值最高的内生增长机会,同时对资本配置和执行保持严格纪律。”

2026年第二季度业绩

除每股金额外,单位为百万

2026年第二季度


2025年第二季度


金额变动


变动百分比

净销售额

$   1,743.3


$   1,330.0


$      413.3


31.1 %

归属于雅宝(Albemarle Corporation)的净利润

$      480.0


$       22.9


$      457.1


1,996.2 %

调整后EBITDA(a)

$      858.1


$      336.5


$      521.6


155.0 %

Diluted income (loss) per share attributable to common
shareholders

$        3.52


$      (0.16)


$       3.68


NM

   非经常性及其他异常项目(a)

0.22


0.27





Adjusted diluted income per share attributable to
common shareholders(a)(b)

$       3.75


$       0.11


$       3.64


NM


(a) 详见非GAAP调节表以了解更多详情。

(b) 由于四舍五入,总计可能无法相加。

2026年第二季度净销售额为17亿美元,上年同期为13亿美元,增长31%,主要受储能和特种材料两大业务价格上涨以及特种材料销量增长推动。调整后EBITDA为8.58亿美元,较上年同期增加5.22亿美元,主要由于净销售额增长以及持续的成本和生产率改善。

归属于雅宝(Albemarle)的净利润为4.8亿美元,同比增加4.57亿美元。2026年第二季度的有效所得税率为21.3%,按调整后口径计算为19.1%。

储能业务业绩

单位:百万

2026年第二季度


2025年第二季度


变动金额(美元)


变动百分比

净销售额

$       1,276.7


$         717.7


$         559.0


77.9 %

销售量(千吨碳酸锂当量)(a)

65


59


6


11.0 %

平均实现价格(美元/千克碳酸锂当量)(a)

$         19.53


$         12.17


$           7.36


60.5 %

调整后EBITDA

$         723.5


$         219.7


$         503.7


229.3 %


(a) 包括按碳酸锂当量(LCE)计算的汇总盐类和锂辉石销量。

2026年第二季度储能业务净销售额为13亿美元,增加5.59亿美元,增幅78%,主要由于定价上升。调整后EBITDA为7.23亿美元,增加5.04亿美元,增幅229%,主要由于锂定价上升,部分被CORFO特许权使用费增加所抵消。

特种产品业绩

单位:百万

2026年第二季度


2025年第二季度


金额变动


变动百分比

净销售额

$         423.5


$         351.6


$           71.9


20.5 %

调整后EBITDA

$         117.7


$           73.0


$           44.7


61.3 %

2026年第二季度特种产品净销售额为4.23亿美元,增加7200万美元,增幅20%,主要由于销量上升(+8%)和定价上涨(+11%)。调整后EBITDA为1.18亿美元,增加4500万美元,增幅61%,主要由于溴及衍生物销量上升和有利定价,以及持续的生产率改善和对中东冲突导致的成本上涨的主动管理。 

2026年展望考量

公司整体展望考量
下表反映了基于近期观察到的锂市场价格情景对公司整体的预期结果。每种情景的展望区间基于销量和产品结构的变化。预计储能产量将同比增长。由于Wodgina产量的增加部分抵消了Talison CGP3因6月9日发生火灾而延迟爬产的影响,销量预计将在22.5万至23.5万吨碳酸锂当量之间。所有三种情景均假设市场价格平稳贯穿储能当前合同簿,其中约40%的盐类销量(即总销量的三分之一)为长期协议。情景还假设锂辉石定价平均为碳酸锂当量(LCE)价格的10%,而其他成本假设保持不变。


公司2026财年预计总计

观察到的市场价格情形(a)

2025财年平均

2026年第一季度平均

2021-2025年平均

锂市场平均价格(美元/千克碳酸锂当量)(a)

约10美元

约20美元

约30美元

净销售额

41亿至43亿美元

57亿至60亿美元

75亿至78亿美元

调整后EBITDA(b)

9亿至10亿美元

24亿至26亿美元

42亿至44亿美元


(a) 价格代表相关市场定价的混合,包括所述期间的现货和区域指数。

(b) 公司不提供前瞻性非GAAP财务指标与按照GAAP计算和报告的最直接可比财务指标之间的调节表,因为公司无法在不付出不合理努力的情况下估计重大非经常性或异常项目。更多信息请参见“关于非GAAP指标的补充信息”。

储能市场价格情景


储能 2026财年预测

观察到的市场价格情形(a)

2025财年平均

2026年第一季度平均

2021-2025年平均

锂市场平均价格(美元/千克碳酸锂当量)(a)

约10美元

约20美元

约30美元

净销售额

25亿至26亿美元

40亿至42亿美元

59亿至61亿美元

调整后EBITDA

7亿至8亿美元

21亿至23亿美元

39亿至41亿美元

未合并投资的净收益权益
(税后)(b)

2亿至3亿美元

6亿至7亿美元

10亿至11亿美元


(a) 价格代表相关市场定价的混合,包括所述期间的现货和区域指数。

(b) 按税前基础计入调整后EBITDA。

特种产品业务展望考量
特种产品业务的净销售额和调整后EBITDA展望有所改善,主要得益于年初至今的强劲表现,这由溴素特种产品的销量增长以及成本和生产率改善所驱动。我们的展望继续反映关键终端市场的温和销量增长,主要由半导体、石油和天然气、阻燃剂和制药领域引领,但部分被汽车和石化领域预期的疲软所抵消。下半年展望假设溴素市场趋于稳定,并持续存在不确定性,包括中东局势。Jordan Bromine Company(JBC)合资企业的运营符合预期,该公司继续应对该地区的地缘政治紧张局势。


2026财年分部预期

特种产品净销售额

14亿至16亿美元

特种产品调整后EBITDA

2.75亿至3.25亿美元

其他公司展望考量
雅宝(Albemarle)预计其2026年全年资本支出约为5亿美元,由于持续的资本效率提升,较2025年下降15%。

继2026年3月2日宣布出售Ketjen炼油催化剂解决方案业务控股权后,炼油催化剂业务的收益现归类为权益收益并计入公司及其他(Corporate),保留的Performance Catalyst Solutions(PCS)业务的业绩亦同样计入。交易完成后,上述业务对调整后EBITDA和权益收益的贡献预计将不重大。

在2026年第一季度完成债务削减行动后,预计2026年的利息和融资费用将在1.2亿美元至1.4亿美元之间。


其他企业 2026财年预计

资本支出

约5亿美元

折旧与摊销

6.6亿至6.8亿美元

调整后有效税率(a)

(50)% - 30%

公司调整后EBITDA(含外汇、Ketjen权益收益及PCS)

(20)至20百万美元

利息和融资费用

1.2亿至1.4亿美元

加权平均流通普通股股数(稀释后)(b)

约1.36亿股


(a)  调整后的实际税率取决于锂市场价格和地域收入结构

(b)  稀释加权平均流通普通股股数假设优先股已转换,且归属于普通股股东的净利润不会被强制可转换优先股股息所减少。如果强制可转换优先股股息的减少导致每股收益更具稀释性,则稀释加权平均流通普通股股数将不假设优先股已转换。

现金流与资本配置
2026年上半年经营活动产生的现金流为11亿美元,较上年同期增加5.18亿美元。2026年前六个月资本支出为1.7亿美元,较上年同期减少1.32亿美元。

资产负债表与流动性
截至2026年6月30日,Albemarle(雅宝)的估计流动性约为32亿美元,其中包括16亿美元现金及现金等价物、循环信贷额度下可用的15亿美元以及其他信贷额度下可用的7800万美元。总债务为19亿美元,净债务与调整后EBITDA之比(按我们信贷协议中的定义)约为0.5(a)。

(a) 详见非GAAP调节表。

财报电话会议

日期:

2026年8月6日,星期四

时间:

美国东部时间上午8:00

电话接入(美国):

1-800-590-8290

电话接入(国际):

1-240-690-8800

会议ID:

ALBQ2

公司的业绩演示文稿及配套材料可在雅宝(Albemarle)网站 https://investors.albemarle.com 上查阅。

关于雅宝(Albemarle)
雅宝公司(Albemarle Corporation,纽约证券交易所代码:ALB)是将关键资源转化为移动出行、能源、连接和健康领域关键成分的全球领导者。我们携手合作,以兼顾人类与地球的方式,开创移动、供能、连接和保护的新途径。可靠且高质量的全球锂和溴供应使我们能够为客户提供先进解决方案。欲了解更多关于雅宝员工如何助力构建更具韧性的世界的信息,请访问 Albemarle.com。

雅宝(Albemarle)定期在 Albemarle.com 发布信息,包括活动通知、新闻、财务业绩、投资者演示和网络直播、非 GAAP 调节表、美国证券交易委员会(U.S. Securities and Exchange Commission)备案文件,以及有关公司、其业务及其所服务市场的其他信息。

前瞻性陈述
本新闻稿包含有关我们对未来的预期、期望和信念的陈述,这些陈述构成1995年《私人证券诉讼改革法案》意义上的“前瞻性陈述”。这些前瞻性陈述基于我们截至本新闻稿发布之日所作的假设,并受已知和未知风险及不确定性的影响,通常包含诸如“雄心”、“预期”、“相信”、“估计”、“期望”、“目标”、“指引”、“打算”、“可能”、“展望”、“情景”、“应当”、“将会”和“将”等词语。  前瞻性陈述可能包括有关以下内容的陈述:我们2026年公司和业务板块展望,包括碳酸锂当量和锂辉石的预期市场价格以及其他基本假设和展望考量;有关客户需求和销售的计划和预期;产量影响;财务灵活性和可选性;锂、锂辉石、溴和锂特种产品(“公司产品”)的预期或实际市场价格;公司产品的供需;长期需求和增长的驱动因素;其他基本假设和展望考量;预期资本配置和支出金额及其对现金流的相应影响;关税和其他贸易限制的预期影响;有关其他矿业权益、资源、储量、项目和活动的计划和预期、复合年增长率、成本削减、转化网络优化、利润率改善、会计费用,以及与并非历史事实的事项相关的所有其他信息。可能导致Albemarle实际结果与任何前瞻性陈述中表达或暗示的展望存在重大差异的因素包括:经济和商业状况的变化;贸易政策和关税的变化;以及客户的财务和经营业绩;客户订单的时间和规模;碳酸锂当量和锂辉石市场价格的波动;潜在产量不足;竞争加剧和重新谈判合同条款的压力;产品或转化需求的变化;原材料和能源的可用性和成本;技术变革和发展;外币波动;法律和政府法规的变化;监管行动、程序、索赔或诉讼;网络安全漏洞、恐怖袭击、工业事故或自然灾害;将人工智能技术整合到我们运营中的相关风险;影响全球贸易的地缘政治冲突和政治动荡,包括中东紧张局势;全球经济和清洁能源倡议;我们留住关键人员和吸引新的熟练人员的能力;通胀或利率的变化;债务和股票市场的波动性和不确定性;收购和剥离交易;项目的时间安排和成功;新运营结构和资产优化活动的预期收益和费用;Albemarle在合资企业和其他项目中的合作伙伴的业绩;信用评级的变化;以及Albemarle不时向SEC提交的报告中详细说明的其他因素,包括Albemarle最近一份10-K表格年度报告以及随后提交的任何10-Q表格季度报告中“风险因素”项下所述的因素,这些报告已提交给SEC,可在Albemarle网站的投资者栏目(investors.albemarle.com)以及SEC网站www.sec.gov上查阅。这些前瞻性陈述仅代表本新闻稿发布之日的情况。除证券和其他适用法律另有要求外,Albemarle不承担在情况发生变化时对任何前瞻性陈述提供任何修订的义务。

雅宝(Albemarle)公司及子公司

合并利润表

(除每股金额外,单位为千美元)(未经审计)


截至三个月


截至六个月


6月30日,


6月30日,


2026


2025


2026


2025

净销售额

$ 1,743,313


$ 1,329,992


$ 3,172,044


$ 2,406,873

销货成本

1,153,012


1,133,116


2,080,777


2,053,698

毛利

590,301


196,876


1,091,267


353,175

销售、一般及行政费用

126,353


132,457


263,759


255,959

重组费用及资产核销

7,337


4,448


33,203


3,385

研发费用

3,667


12,444


12,837


26,543

出售业务亏损

—


—


95,018


—

营业收入

452,944


47,527


686,450


67,288

利息及融资费用

(30,924)


(49,939)


(64,045)


(98,916)

其他收入(费用)净额

19,629


(6,559)


73,439


3,691

所得税及未合并投资净收益中的权益前收入(亏损)

441,649


(8,971)


695,844


(27,937)

所得税费用

94,002


34,094


115,513


30,116

Income (loss) before equity in net income of
unconsolidated investments

347,647


(43,065)


580,331


(58,053)

未合并投资的净收益权益
(税后)

151,564


78,258


247,857


142,544

净利润

499,211


35,193


828,188


84,491

归属于非控股权益的净利润

(19,252)


(12,296)


(29,138)


(20,246)

归属于雅宝(Albemarle Corporation)的净利润

479,959


22,897


799,050


64,245

强制性可转换优先股股息

(41,687)


(41,687)


(83,375)


(83,375)

归属于雅宝(Albemarle Corporation)
普通股股东的净利润(亏损)

$   438,272


$   (18,790)


$   715,675


$   (19,130)

归属于普通股
股东的基本每股收益(亏损)

$        3.72


$      (0.16)


$        6.07


$      (0.16)

Diluted earnings (loss) per share attributable to
common shareholders

$        3.52


$      (0.16)


$        5.87


$      (0.16)









加权平均流通普通股股数——基本

117,961


117,665


117,907


117,634

加权平均流通普通股——
稀释后

136,212


117,665


136,170


117,634

雅宝公司(Albemarle Corporation)及子公司

简明合并资产负债表

(单位:千美元)(未经审计)


6月30日,


12月31日,


2026


2025

资产




流动资产:




现金及现金等价物

$       1,631,688


$       1,618,001

应收账款

603,805


593,502

其他应收款

123,870


105,110

存货

1,384,563


1,179,271

其他流动资产

200,275


140,440

持有待售流动资产

—


371,815

流动资产合计

3,944,201


4,008,139

物业、厂房及设备

11,902,156


11,768,840

减:累计折旧及摊销

3,442,831


3,156,429

物业、厂房及设备净额

8,459,325


8,612,411

投资

1,109,241


900,926

其他资产

707,577


647,185

商誉

1,482,672


1,499,657

其他无形资产,扣除摊销

202,079


214,233

持有待售非流动资产

—


491,660

总资产

$     15,905,095


$     16,374,211

负债和权益




流动负债:




应付第三方账款

$         670,229


$         779,160

应付关联方账款

445,421


134,369

应计费用

507,556


521,831

长期债务的当期部分

74,677


74,077

应付股利

61,514


61,387

应交所得税

131,703


35,467

持有待售的流动负债

—


191,753

流动负债合计

1,891,100


1,798,044

长期债务

1,802,107


3,119,464

退休后福利

45,198


44,744

养老金福利

105,729


117,361

其他非流动负债

1,158,555


1,084,892

递延所得税

368,552


368,275

持有待售非流动负债

—


59,970

承诺和或有事项




权益:




雅宝(Albemarle)公司股东权益:




普通股

1,180


1,178

强制可转换优先股

2,235,105


2,235,105

额外实收资本

3,048,664


3,018,213

累计其他综合亏损

(243,599)


(334,807)

留存收益

5,233,819


4,613,676

雅宝(Albemarle Corporation)股东权益总额

10,275,169


9,533,365

非控股权益

258,685


248,096

权益总额

10,533,854


9,781,461

负债和权益总计

$     15,905,095


$     16,374,211

雅宝(Albemarle)公司及子公司

部分合并现金流量数据

(单位:千美元)(未经审计)


截至

6月30日的六个月


2026


2025

年初现金及现金等价物

$  1,618,001


$  1,192,230

经营活动产生的现金流量:




净利润

828,188


84,491

将净利润调节为经营活动现金流量的调整项目:




折旧与摊销

313,606


330,485

出售业务损失

95,018


—

出售股权投资收益

(42,300)


—

股份支付及其他

14,661


17,068

未合并投资的净收益权益(税后净额)

(247,857)


(142,544)

从非合并投资及非流通证券收到的股息

131,744


67,765

养老金及退休后福利费用

5,299


3,504

养老金及退休后缴款

(14,298)


(9,934)

有价证券投资的未实现(收益)损失

(2,792)


4,984

债务提前清偿收益

(12,543)


—

递延所得税

(19,798)


(38,907)

营运资金变动

(53,125)


(96,762)

非流动负债变动及其他,净额

60,438


318,030

经营活动提供的现金净额

1,056,241


538,180

投资活动产生的现金流量:




资本支出

(170,407)


(302,252)

出售业务所得款项,扣除所售现金

525,156


—

出售财产和设备所得款项

—


23,751

出售投资所得款项

123,270


—

出售可供出售债务证券所得款项

—


288,000

(Payments) proceeds from settlement of foreign currency forward contracts,
net

(18,772)


171,262

有价证券销售净额

1,392


2,971

对权益投资及非流通证券的投资

(119)


(120)

投资活动提供的现金净额

460,520


183,612

筹资活动产生的现金流量:




长期债务和信贷协议的偿还

(1,314,151)


(29,103)

长期债务及信贷协议借款所得

35,952


19,488

其他债务偿还,净额

(12,309)


(2,427)

与提前清偿债务相关的费用

(1,686)


—

支付给普通股股东的股息

(95,372)


(95,244)

支付给强制可转换优先股股东的股息

(83,375)


(83,375)

支付给非控股权益的股息

(37,463)


(18,169)

行使股票期权所得款项

19,635


1,186

就股票薪酬奖励分配支付的预扣税

(4,199)


(2,941)

Other

(438)


(55)

Net cash used in financing activities

(1,493,406)


(210,640)

Net effect of foreign exchange on cash and cash equivalents

(9,668)


103,447

Increase in cash and cash equivalents

13,687


614,599

Cash and cash equivalents at end of period

$  1,631,688


$  1,806,829

Albemarle Corporation and Subsidiaries

Consolidated Summary of Segment Results

(In Thousands) (Unaudited) 


Three Months Ended


Six Months Ended


June 30,


June 30,


2026


2025


2026


2025

Net sales:








Energy Storage

$             1,276,684


$                717,656


$             2,167,849


$             1,242,221

Specialties

423,484


351,560


781,897


672,574

Total segment net sales

1,700,168


1,069,216


2,949,746


1,914,795

Corporate and all other

43,145


260,776


222,298


492,078

Total net sales

$             1,743,313


$             1,329,992


$             3,172,044


$             2,406,873









Adjusted EBITDA:








Energy Storage

$                723,457


$                219,725


$             1,274,813


$                406,080

Specialties

117,720


72,977


193,849


131,643

Total segment adjusted EBITDA

841,177


292,702


1,468,662


537,723

Corporate and all other

16,920


43,773


53,249


65,896

Total adjusted EBITDA

$                858,097


$                336,475


$             1,521,911


$                603,619

See accompanying non-GAAP reconciliations below.

Additional Information Regarding Non-GAAP Measures

It should be noted that adjusted net income attributable to Albemarle Corporation, adjusted net income (loss) attributable to Albemarle Corporation common shareholders, adjusted diluted income (loss) per share attributable to common shareholders, non-operating pension and other post-employment benefit ("OPEB") items per diluted share, non-recurring and other unusual items per diluted share, adjusted effective income tax rates, EBITDA, adjusted EBITDA (on a consolidated basis), EBITDA margin, adjusted EBITDA margin, operating cash flow conversion and net debt to adjusted EBITDA ratio are financial measures that are not required by, or presented in accordance with, accounting principles generally accepted in the United States, or GAAP. These non-GAAP measures should not be considered as alternatives to Net income attributable to Albemarle Corporation ("earnings") or other comparable measures calculated and reported in accordance with GAAP. These measures are presented here to provide additional useful measurements to review the company's operations, provide transparency to investors and enable period-to-period comparability of financial performance. The company's chief operating decision maker uses these measures to assess the ongoing performance of the company and its segments, as well as for business and enterprise planning purposes.

A description of other non-GAAP financial measures that Albemarle uses to evaluate its operations and financial performance, and reconciliation of these non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP can be found on the following pages of this press release, which is also is available on Albemarle's website at https://investors.albemarle.com. The company does not provide a reconciliation of forward-looking non-GAAP financial measures to the most directly comparable financial measures calculated and reported in accordance with GAAP, as the company is unable to estimate significant non-recurring or unusual items without unreasonable effort. The amounts and timing of these items are uncertain and could be material to the company's results calculated in accordance with GAAP.

ALBEMARLE CORPORATION AND SUBSIDIARIES

Non-GAAP Reconciliations

(Unaudited)

See below for a reconciliation of adjusted net income attributable to Albemarle Corporation, adjusted net income (loss) attributable to Albemarle Corporation common shareholders, EBITDA and adjusted EBITDA (on a consolidated basis), which are non-GAAP financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance with GAAP. Adjusted net income attributable to Albemarle Corporation is defined as net income attributable to Albemarle Corporation before the non-recurring, other unusual and non-operating pension and other post-employment benefit (OPEB) items as listed below. The non-recurring and unusual items may include acquisition and integration related costs, gains or losses on sales of businesses, restructuring charges, facility divestiture charges, certain litigation and arbitration costs and charges, and other significant non-recurring items. Adjusted net income (loss) attributable to Albemarle Corporation common stockholders is defined as adjusted net income attributable to Albemarle Corporation after mandatory convertible preferred stock dividends. EBITDA is defined as net income attributable to Albemarle Corporation before interest and financing expenses, income tax expense (benefit), and depreciation and amortization. Adjusted EBITDA is defined as EBITDA plus or minus the proportionate share of Windfield Holdings income tax expense, non-recurring and other unusual items, and non-operating pension and OPEB items as listed below.


Three Months Ended


Six Months Ended


June 30,


June 30,


2026


2025


2026


2025

In thousands, except percentages and per
share amounts

$


% of
net
sales


$


% of
net
sales


$


% of
net
sales


$


% of
net
sales

Net income attributable to Albemarle
Corporation

$479,959




$ 22,897




$            799,050




$ 64,245



Add back:
















Non-operating pension and OPEB items
(net of tax)

626




169




1,597




294



Non-recurring and other unusual items (net
of tax)

30,555




31,708




111,945




10,508



Adjusted net income attributable to Albemarle
Corporation

511,140




54,774




912,592




75,047



    Mandatory convertible preferred stock
dividends(a)

—




(41,687)




—




(83,375)



Adjusted net income (loss) attributable to
Albemarle Corporation common shareholders

$511,140




$ 13,087




$            912,592




$ (8,328)



















Adjusted diluted income (loss) per share
attributable to common shareholders

$   3.75




$   0.11




$   6.70




$  (0.07)



















Adjusted weighted-average common shares
outstanding – diluted(a)

136,212




117,691




136,170




117,634



















Net income attributable to Albemarle
Corporation

$479,959


27.5 %


$ 22,897


1.7 %


$            799,050


25.2 %


$ 64,245


2.7 %

Add back:
















Interest and financing expenses

30,924


1.8 %


49,939


3.8 %


64,045


2.0 %


98,916


4.1 %

Income tax expense

94,002


5.4 %


34,094


2.6 %


115,513


3.6 %


30,116


1.3 %

Depreciation and amortization

155,801


8.9 %


168,731


12.7 %


313,606


9.9 %


330,485


13.7 %

EBITDA

760,686


43.6 %


275,661


20.7 %


1,292,214


40.7 %


523,762


21.8 %

Proportionate share of Windfield income
tax expense

70,766


4.1 %


33,150


2.5 %


112,300


3.5 %


58,476


2.4 %

Non-operating pension and OPEB items

854


— %


336


— %


2,201


0.1 %


611


— %

Non-recurring and other unusual items

25,791


1.5 %


27,328


2.1 %


115,196


3.6 %


20,770


0.9 %

Adjusted EBITDA

$858,097


49.2 %


$            336,475


25.3 %


$             1,521,911


48.0 %


$            603,619


25.1 %

















Net sales

$             1,743,313




$             1,329,992




$             3,172,044




$             2,406,873



(a) Calculation of adjusted diluted income (loss) per share attributable to common shareholders for the three and six months ended June 30, 2026 excludes $41.7 million and $83.4 million, respectively, of mandatory convertible preferred stock dividends and includes the assumed conversion of preferred stock into the diluted shares outstanding, as this results in the more dilutive per share result.

Non-operating pension and OPEB items, consisting of mark-to-market actuarial gains/losses, settlements/curtailments, interest cost and expected return on assets, are not allocated to Albemarle's operating segments and are included in the Corporate and all other category. In addition, the company believes that these components of pension cost are mainly driven by market performance, and the company manages these separately from the operational performance of the company's businesses. In accordance with GAAP, these non-operating pension and OPEB items are included in Other income (expenses), net. Non-operating pension and OPEB items were as follows (in thousands):


Three Months Ended


Six Months Ended


June 30,


June 30,


2026


2025


2026


2025

Interest cost

$     8,994


$     8,924


$    18,035


$    17,734

Expected return on assets

(8,140)


(8,588)


(15,834)


(17,123)

Total

$        854


$        336


$     2,201


$        611

In addition to the non-operating pension and OPEB items disclosed above, the company has identified certain other items and excluded them from Albemarle's adjusted net income (loss) calculation for the periods presented. A listing of these items, as well as a detailed description of each follows below (per diluted share):


Three Months Ended


Six Months Ended


June 30,


June 30,


2026


2025


2026


2025

Restructuring charges and asset write-offs(1)

$       0.05


$       0.02


$       0.24


$       0.01

Acquisition and integration related costs(2)

0.01


0.01


0.01


0.02

Loss on sale of business/equity investment, net(3)

—


—


0.39


—

Gain on early extinguishment of debt(4)

—


—


(0.09)


—

(Gain) loss in fair value of public equity securities(5)

(0.05)


—


(0.01)


0.03

Other(6)

0.17


0.13


0.20


0.05

Tax related items(7)

0.04


0.11


0.08


(0.02)

Total non-recurring and other unusual items

$       0.22


$       0.27


$       0.82


$       0.09



(1)

In 2026, the Company announced it would place Kemerton Train 1 into care and maintenance. As a result, and in addition to other previously announced restructuring actions, the Company recorded charges of $7.3 million and $33.2 million in Restructuring charges and asset write-offs for the three and six months ended June 30, 2026, respectively. Due to the impact of valuation allowances, this resulted in total after-tax charges of $7.5 million and $33.3 million, or $0.05 and $0.24 per share, for the three and six months ended June 30, 2026, respectively. The three and six months ended June 30, 2025 included certain restructuring costs and adjustments to previously recorded costs related to restructuring actions originally entered into in 2024. As a result, the Company recorded charges of $4.4 million and $3.4 million in Restructuring charges and asset write-offs and gains (losses) of $0.1 million and ($0.1) million in Other income (expenses), net for the three and six months ended June 30, 2025, respectively. Due to the impact of valuation allowances, this resulted in total after-tax gains of $2.9 million and $0.8 million, or $0.02 and $0.01 per share, for the three and six months ended June 30, 2025, respectively.



(2)

Costs related to the acquisition, integration and divestitures for various significant projects, recorded in Selling, general and administrative expenses for the three and six months ended June 30, 2026 were $0.8 million and $1.9 million ($0.01 and $0.01 per share, with no income tax effect due to the impact of valuation allowances), respectively, and for the three and six months ended June 30, 2025 were $1.8 million and $3.2 million ($1.4 million and $2.5 million after income taxes, or $0.01 and $0.02 per share), respectively.



(3)

During the first quarter of 2026, the Company divested its controlling ownership interest in its Refining Solutions business and its full 50% ownership interest in the Eurecat joint venture. As a result of these transactions, the Company recorded a net loss of $52.7 million ($0.39 per share, with no income tax effect due to the impact of valuation allowances), representing the proceeds received less the carrying value as of the transaction dates.



(4)

During the first quarter of 2026, the Company completed a $1.3 billion debt tender and redemption, resulting in a gain on early extinguishment of debt of $12.5 million ($0.09 per share, with no income tax effect due to the impact of valuation allowances), representing the repurchase of this debt at a discount, partially offset by tender premiums and redemption fees.



(5)

Gains resulting from the net change in fair value of investments in public equity securities, recorded in Other income (expenses), net for the three and six months ended June 30, 2026 of $6.5 million and $1.0 million ($0.05 and $0.01 per share, with no income tax effect due to the impact of valuation allowances), respectively, and for the three and six months ended June 30, 2025 gains (losses) of $0.2 million and ($4.8) million ($0.1 million and ($3.8 million) after income taxes, or less than $0.01 and $0.03 per share), respectively.



(6)

Other adjustments for the three months ended June 30, 2026 included amounts recorded in:


  • Cost of goods sold - $3.9 million of expenses related to non-routine labor and compensation related costs that are outside normal compensation arrangements.

  • Selling, general and administrative expenses - Primarily comprised of $19.0 million of expenses, mainly consulting fees, related to the Company's strategic cost savings initiative.

  • Other income (expenses), net - Primarily related to $3.4 million of charges for asset retirement obligations at a site not part of our operations and a net loss of $1.5 million primarily driven by indemnification charges related to the Eurecat S.A. joint venture sale, partially offset by a $3.9 million gain resulting from the adjustment of indemnification related to previously disposed businesses.

After income taxes, these net losses totaled $22.8 million, or $0.17 per share.




Other adjustments for the three months ended June 30, 2025 included amounts recorded in:


  • Selling, general and administrative expenses - $8.3 million of gains from the sale of assets not part of our production operations, partially offset by $1.8 million of severance expenses not related to a restructuring plan.

  • Other income (expenses), net - $38.0 million loss resulting from the redemption of preferred equity in a Grace subsidiary, partially offset by $10.1 million of income from PIK dividends of that preferred equity prior to redemption.

After income taxes, these net losses totaled $15.3 million, or $0.13 per share.




Other adjustments for the six months ended June 30, 2026 included amounts recorded in:


  • Cost of goods sold - $3.9 million of expenses related to non-routine labor and compensation related costs that are outside normal compensation arrangements.

  • Selling, general and administrative expenses - Primarily comprised of $19.0 million of expenses, mainly consulting fees, related to the Company's strategic cost savings initiative and a $3.9 million charge for a non-income tax audit of a facility no longer controlled by the Company.

  • Other income (expenses), net - Primarily related to $3.4 million of charges for asset retirement obligations at a site not part of our operations and a net loss of $1.5 million primarily driven by indemnification charges related to the Eurecat S.A. joint venture sale, partially offset by a $3.9 million gain resulting from the adjustment of indemnification related to previously disposed businesses.

After income taxes, these net losses totaled $27.0 million, or $0.20 per share.




Other adjustments for the six months ended June 30, 2025 included amounts recorded in:


  • Selling, general and administrative expenses - $11.4 million of gains from the sale of assets not part of our production operations, partially offset by $1.8 million of severance expenses not related to a restructuring plan and $0.6 million of expenses related to certain historical legal matters.

  • Other income (expenses), net - $38.0 million loss resulting from the redemption of preferred equity in a Grace subsidiary and $1.9 million of charges for asset retirement obligations at a site not part of our operations, partially offset by $19.8 million of income from PIK dividends of the preferred equity in a Grace subsidiary prior to redemption and a $1.9 million gain primarily resulting from the adjustment of indemnification related to previously disposed businesses.

After income taxes, these net losses totaled $5.4 million, or $0.05 per share.



(7)

Included in Income tax expense for the three and six months ended June 30, 2026 are discrete net tax expenses of $6.0 million and $10.6 million, or $0.04 and $0.08 per share, respectively, primarily related to the impact of foreign tax reserves and foreign return to provisions.




Included in Income tax expense for the three and six months ended June 30, 2025 are discrete net tax expenses of $12.2 million, or $0.11 per share, and benefits of $2.0 million, or $0.02 per share, respectively, primarily related to the impact of foreign tax reserves and excess tax benefits realized from stock-based compensation arrangements.

See below for a reconciliation of the adjusted effective income tax rate, the non-GAAP financial measure, to the effective income tax rate, the most directly comparable financial measure calculated and reporting in accordance with GAAP (in thousands, except percentages).


Income (loss) before
income taxes and
equity in net income
of unconsolidated
investments


Income tax expense
(benefit)


Effective income tax
rate

Three months ended June 30, 2026






As reported

$             441,649


$              94,002


21.3 %

Non-recurring, other unusual and non-operating pension and OPEB
items

26,691


(4,490)



As adjusted

$             468,340


$              89,512


19.1 %







Three months ended June 30, 2025






As reported

$              (8,971)


$              34,094


(380.0) %

Non-recurring, other unusual and non-operating pension and OPEB
items

27,664


(4,213)



As adjusted

$              18,693


$              29,881


159.9 %







Six months ended June 30, 2026






As reported

$             695,844


$             115,513


16.6 %

Non-recurring, other unusual and non-operating pension and OPEB
items

104,853


(8,689)



As adjusted

$             800,697


$             106,824


13.3 %







Six months ended June 30, 2025






As reported

$             (27,937)


$              30,116


(107.8) %

Non-recurring, other unusual and non-operating pension and OPEB
items

21,381


10,579



As adjusted

$              (6,556)


$              40,695


(620.7) %

See below for the calculation of operating cash flow conversion and a reconciliation of free cash flow, a non-GAAP measure, to net cash provided by operating activities, the most directly comparable financial measure calculated and reporting in accordance with GAAP. The Company defines operating cash flow conversion as Net cash provided by operating activities from the statement of cash flows divided by adjusted EBITDA, which is a non-GAAP measure. A reconciliation of adjusted EBITDA, the non-GAAP financial measure, from net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reporting in accordance with GAAP, is provided in the above tables (in thousands, except percentages).


Three Months Ended


June 30, 2026

Free cash flow:


Net cash provided by operating activities

$               709,997

Less: Capital expenditures

(71,731)

Free cash flow

$               638,266



Operating cash flow conversion:


Net cash provided by operating activities

$               709,997



Adjusted EBITDA

$               858,097



Operating cash flow conversion

83 %

See below for the calculation of the net debt to adjusted EBITDA ratio ("Consolidated Leverage Ratio," as defined in our credit agreement), a non-GAAP financial measure, for the twelve months ended June 30, 2026 (in thousands, except ratio).


Twelve Months Ended


June 30, 2026

Adjusted EBITDA

$               2,016,285

Equity in net income of non-Windfield Holdings unconsolidated investments (net of tax)

544

Dividends received from non-Windfield Holdings unconsolidated investments

9,804

Consolidated Windfield-Adjusted EBITDA

$               2,026,633



Total Albemarle Corporation long-term debt (as reported)

$               1,876,784

49% Windfield Holdings debt

718,079

Off-balance sheet obligations and other

95,200

Consolidated Windfield-Adjusted Funded Debt

$               2,690,063

Less Cash

1,631,688

Less 49% Windfield Holdings cash

62,249

Consolidated Windfield-Adjusted Funded Net Debt

$                 996,126



Consolidated Leverage Ratio

0.5

Contact:

[email protected]

1.980.308.6194

View original content to download multimedia:https://www.prnewswire.com/news-releases/albemarle-reports-second-quarter-2026-results-302844113.html

SOURCE Albemarle Corporation

Source: 雅宝 · 官方动态 · albemarle.com

Licence: 负责人声明许可;来源异议或指示可逐项收紧

The original source is traceable; the Chinese content is written or translated with AI assistance ; check the original for details.

Something wrong? Tell us

Companies in this article

  • 雅宝

    全球锂和溴生产商,2026年二季度净销售额17亿美元,同比增长31%,调整后EBITDA 8.58亿美元。

    Source of the data: 原文依据

More actions